Jewell Christopher M
SEC CIK 2000226 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics, Inc. | CSO | 62.5K | — | $917.8K | 7 | 2024-01-02 | 2025-01-10 |
Most active insiders at RNAC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BARABE TIMOTHY C | Dir | $205.8K | — |
| 2 | Brunn Carsten | Pres, CEO, Dir | — | $162.1K |
| 3 | Davis Blaine | CFO | — | $72.2K |
| 4 | Miljkovic Milos | Chief Medical Off | — | $24.4K |
| 5 | Bot Adrian Ion | Dir | — | — |
| 6 | Seymour June Ann | CAO | — | — |
| 7 | English Emily | Chief Ops Off | — | — |
| 8 | Hoge Elizabeth | 10% | — | — |
| 9 | Singer Michael | Dir | — | — |
| 10 | Kalayoglu Murat | Dir, 10% | — | — |
Jewell Christopher M made no open-market trades at RNAC in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-13 | 2025-01-10 | RNAC | Cartesian Therapeutics, Inc. | Jewell Christopher M | CSO | M - OptEx | $3.23 | +9,000 | 62.5K | +17% | +$29.1K |
| M | 2025-01-07 | 2025-01-03+ | RNAC | Cartesian Therapeutics, Inc. | Jewell Christopher M | CSO | S - Sale | $16.78 | -2,550 | 53.5K | -5% | -$42.8K |
| D | 2025-01-06 | 2025-01-02 | RNAC | Cartesian Therapeutics, Inc. | Jewell Christopher M | CSO | A - Grant | $0.00 | +16.1K | 56.0K | +40% | $0 |
| D | 2024-11-21 | 2024-11-20 | RNAC | Cartesian Therapeutics, Inc. | Jewell Christopher M | CSO | M - OptEx | $3.23 | +14.0K | 39.9K | +54% | +$45.2K |
| DM | 2024-11-18 | 2024-11-14+ | RNAC | Cartesian Therapeutics, Inc. | Jewell Christopher M | CSO | M - OptEx | $3.23 | +52.1K | 42.0K | New | +$168.3K |
| DM | 2024-11-18 | 2024-11-14+ | RNAC | Cartesian Therapeutics, Inc. | Jewell Christopher M | CSO | S - Sale+OE | $16.79 | -52.1K | 25.9K | -67% | -$875.0K |
| D | 2024-01-04 | 2024-01-02 | RNAC | Cartesian Therapeutics, Inc. | Jewell Christopher M | CSO | A - Grant | $0.00 | +778.2K | 778.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations